MedTrace Logo

SOLTIVE™ Laser Enucleation for Treatment of Benign Prostatic Hyperplasia

NCT04826887 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 15

Last updated 2024-10-02

No results posted yet for this study

Summary

To compare intraoperative as well as postoperative outcomes of SOLTIVE Thulium Fiber Laser Enucleation of the Prostate (ThuFLEP) vs Holmium Laser Enucleation of the Prostate.

Our hypothesis is that utilizing the SOLTIVE Thulium laser enucleation of the prostate will result in a more efficient procedure, comparable results to that of Holmium laser enucleation of the prostate and subjective improvement of prior device limitations

Conditions

  • BPH
  • Benign Prostatic Hyperplasia

Interventions

OTHER

SOLTIVE Thulium Laser

Use of SOLTIVE Thulium laser for HoLEP

OTHER

Standard of Care (Holmium Laser)

Use of Holmium laser for HoLEP

Sponsors & Collaborators

  • University of Kansas Medical Center

    lead OTHER

Principal Investigators

  • Donald Neff · University of Kansas Medical Center

Eligibility

Min Age
18 Years
Sex
MALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2021-04-14
Primary Completion
2022-11-30
Completion
2024-05-02

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04826887 on ClinicalTrials.gov